DelveInsight’s “Acute Kidney Injury Market Insight, Epidemiology and Market Forecast 2032” report provides current treatment practices, emerging drugs, Acute Kidney Injury market share of the individual therapies, current and forecasted Acute Kidney Injury market size from 2019 to 2032 segmented by seven major markets. The report also offers current Acute Kidney Injury therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Kidney Injury market.

 

Acute Kidney Injury Overview

Acute Kidney Injury is commonly defined as an abrupt decline in renal function, clinically manifesting as a reversible acute increase in nitrogen waste products measured by blood urea nitrogen (BUN) and serum creatinine levels over the course of hours to weeks. Signs and symptoms of AKI includes, nausea, vomiting, weakness, dizziness and, pain in lower back. Some patients are asymptomatic (no noticeable symptoms) and others may have generalized non-specific (not specific to kidneys) symptoms.

 

Acute Kidney Injury Epidemiological Insights

The United States contributed to the largest incident population of Acute Kidney Injury, accounting for ~ 34% of the 7MM in 2021, asserts DelveInsight.

 

Acute Kidney Injury Treatment Market 

Acute Kidney Injury pipeline with a novel mechanism of action and increasing incidence are major market drivers of AKI market. Additionally, the AKI pipeline is also expected to change the current dynamics of the market, which presently comprises biologics and molecules with new mechanisms of action.

Currently, there are no targeted pharmacotherapies approved for the treatment of AKI. At present, the therapeutic market size of AKI is mainly dominated by the use of Renal Replacement Therapy (RRT) and off-label drugs, which include various classes such as ACE inhibitors, Angiotensin II-Receptor Blockers (ARBs), Diuretics, and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

 

Promising Therapies in the Acute Kidney Injury Pipeline

• SB-101
• RMC-035 (ROSgard)
• OCE-205
• RBT-1
• And others

 

Discover more about Acute Kidney Injury therapies in the pipeline @ Acute Kidney Injury Drugs

 

Leading Companies Working in the Acute Kidney Injury Market

• Sentien Biotechnologies
• Guard Therapeutics
• Ocelot Bio
• Renibus Therapeutics
• And others

 

To understand key companies related to the Acute Kidney Injury Market, get a snapshot of the Acute Kidney Injury Regulatory and Patent Analysis.

 

Scope of the Acute Kidney Injury Market Report

Study Period: 2019–2032

Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]

Key Acute Kidney Injury Companies: Sentien Biotechnologies, Guard Therapeutics, Ocelot Bio, Renibus Therapeutics, and others

Key Acute Kidney Injury Pipeline Therapies: SB-101, RMC-035 (ROSgard), OCE-205, RBT-1, and others

Therapeutic Assessment: Acute Kidney Injury current marketed and emerging therapies

Acute Kidney Injury Market Dynamics: Acute Kidney Injury market drivers and barriers 

Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

Unmet Needs, KOL’s views, Analyst’s views, Acute Kidney Injury Market Access and Reimbursement

 

Table of Contents

1. Acute Kidney Injury Market Key Insights

2. Acute Kidney Injury Market Report Introduction

3. Acute Kidney Injury Market Overview at a Glance

4. Acute Kidney Injury Market Executive Summary

5. Disease Background and Overview

6. Acute Kidney Injury Treatment and Management

7. Acute Kidney Injury Epidemiology and Patient Population

8. Patient Journey

9. Acute Kidney Injury Emerging Drugs

10. 7MM Acute Kidney Injury Market Analysis

11. Acute Kidney Injury Market Outlook

12. Potential of Current and Emerging Therapies

13. KOL Views

14. Acute Kidney Injury Market Drivers

15. Acute Kidney Injury Market Barriers

16. Unmet Needs

17. SWOT Analysis

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

Trending Report Offerings by DelveInsight:

• Gender Dysphoria Market
• Germany Healthcare Outlook Market
• Hyperlipidemia Market
• Mammography Devices Market
• Dental Equipment Market
• Adalimumab Biosimilar Market
• Medical Marijuana Market
• Hyperlipidemia Market
• Metastatic Cutaneous Squamous Cell Cancer Market
• Mucopolysaccharidosis Market

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

 

Contact Us

Kritika Rehani

info@delveinsight.com 

+1(919)321-6187 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/